Company intelligence / Profile preview

NOWATCH

Ownership: Private
Employees: ~41
Development stage: Commercial

Overview

NOWATCH offers a commercial wearable device that tracks stress, sleep, and activity using biosensing technology (EDA/skin conductance), providing actionable insights to improve mental and physical health. The product differentiates between physical and emotional stress, supports habit tracking, and delivers personalized feedback via an app. No clinical trial results are reported; the focus is on consumer wellness rather not regulated medical claims.[1][2][3][4][6]

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on NOWATCH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOWATCH.

Explore the full profile